Donato Pacione
Donato Pacione has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Caleb Rutledge
Department of Neurosurgery, NYU Grossman School of Medicine, New York, New York, USA
2 shared publicationsCharlotte Chung
Department of Neurosurgery, NYU Grossman School of Medicine, New York, New York, USA
2 shared publications- Els Fieremans
Center for Advanced Imaging Innovation and Research (CAI2R), Department of Radiology New York University School of Medicine New York New York USA
2 shared publications Erez Nossek
Department of Neurosurgery, NYU Grossman School of Medicine, New York, New York, USA
2 shared publications- Eric Alexander Grin
Department of Neurosurgery, New York University Langone Health, New York, New York, USA
2 shared publications - Eytan Raz
Department of Radiology and Neurosurgery, NYU Langone Health, New York, New York, USA
2 shared publications
Latest Publications
- 28 April 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (1) , 147-152
Neurovascular Pathology in Intracranial Mucormycosis: Treatment by Cranial Bypass and Literature Review
BACKGROUND AND IMPORTANCE: Rhino-orbital cerebral mucormycosis (ROCM) is an aggressive fungal infection involving the paranasal sinuses, orbit, and intracranial cavity, with a propensity for vascular invasion. This can lead to complications such as internal carotid artery (ICA) thrombosis and occlusion, presenting major neurosurgical challenges. Although surgical debridement and antifungal therapy are the mainstays of treatment, cases with significant neurovascular involvement require specialized intervention. We report a case of ROCM with severe flow-limiting ICA stenosis treated by direct extracranial-intracranial bypass. CLINICAL PRESENTATION: tA 65-year-old man with diabetes presented with progressive left-sided blindness and facial numbness. Imaging revealed a left orbital mass extending into the paranasal sinuses and intracranially. Empiric antifungal therapy was started. Pathology confirmed Rhizopus species. Despite extensive surgical debridement and antifungal therapy, the patient developed progressive severe cavernous ICA stenosis, leading to watershed territory strokes. To restore cerebral perfusion, protect from distal emboli, and prepare for potential aggressive debridement, a flow-replacing direct (superficial temporal artery–middle cerebral artery (M2)) bypass was performed, and the supraclinoid carotid was trapped. Intraoperative angiography confirmed robust flow through the bypass. The patient was discharged on antifungal therapy and aspirin. At 6-month follow-up, the patient was neurologically intact with an modified Rankin Scale score of 1. Computed tomography angiography and transcranioplasty Doppler ultrasonography confirmed good flow through the bypass. CONCLUSION: In addition to antifungal therapy and surgical debridement, superficial temporal artery–middle cerebral artery bypass can be a lifesaving intervention in the management of ROCM with severe cerebrovascular compromise. This case highlights the critical role of cranial bypass in preserving cerebral perfusion in patients with flow-limiting ROCM-associated ICA invasion.
- 28 April 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (1) , 147-152
Neurovascular Pathology in Intracranial Mucormycosis: Treatment by Cranial Bypass and Literature Review
BACKGROUND AND IMPORTANCE: Rhino-orbital cerebral mucormycosis (ROCM) is an aggressive fungal infection involving the paranasal sinuses, orbit, and intracranial cavity, with a propensity for vascular invasion. This can lead to complications such as internal carotid artery (ICA) thrombosis and occlusion, presenting major neurosurgical challenges. Although surgical debridement and antifungal therapy are the mainstays of treatment, cases with significant neurovascular involvement require specialized intervention. We report a case of ROCM with severe flow-limiting ICA stenosis treated by direct extracranial-intracranial bypass. CLINICAL PRESENTATION: tA 65-year-old man with diabetes presented with progressive left-sided blindness and facial numbness. Imaging revealed a left orbital mass extending into the paranasal sinuses and intracranially. Empiric antifungal therapy was started. Pathology confirmed Rhizopus species. Despite extensive surgical debridement and antifungal therapy, the patient developed progressive severe cavernous ICA stenosis, leading to watershed territory strokes. To restore cerebral perfusion, protect from distal emboli, and prepare for potential aggressive debridement, a flow-replacing direct (superficial temporal artery–middle cerebral artery (M2)) bypass was performed, and the supraclinoid carotid was trapped. Intraoperative angiography confirmed robust flow through the bypass. The patient was discharged on antifungal therapy and aspirin. At 6-month follow-up, the patient was neurologically intact with an modified Rankin Scale score of 1. Computed tomography angiography and transcranioplasty Doppler ultrasonography confirmed good flow through the bypass. CONCLUSION: In addition to antifungal therapy and surgical debridement, superficial temporal artery–middle cerebral artery bypass can be a lifesaving intervention in the management of ROCM with severe cerebrovascular compromise. This case highlights the critical role of cranial bypass in preserving cerebral perfusion in patients with flow-limiting ROCM-associated ICA invasion.
- 23 September 2024
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 28 (6) , 808-816
Treatment of Acute Iatrogenic Cerebrovascular Injury Using Flow Diverter Stents
BACKGROUND AND OBJECTIVES: Iatrogenic cerebrovascular injury can cause intracranial hemorrhage and pseudoaneurysm formation, putting patients at high risk for postoperative bleeding. No consensus for management exists. This study describes endovascular treatment of these acute injuries with flow diverter stents. METHODS: Electronic medical records were retrospectively reviewed for injury type and etiology, timing of diagnosis, and endovascular management, including antiplatelet regimens, embolization results, and clinical outcome. RESULTS: Six patients were included. Three suffered an injury to the internal carotid artery, 1 suffered an injury to the left anterior cerebral artery, 1 suffered an injury to the right posterior cerebral artery, and 1 suffered an injury to the basilar artery. Four of the 6 injuries occurred during attempted tumor resection, 1 occurred during cerebrospinal fluid leak repair, and 1 occurred during an ophthalmic artery aneurysm clipping. All injuries resulted in pseudoaneurysm formation. Four were immediately detected on angiography; 2 were initially negative on imaging. Five were treated with a pipeline embolization device, and 1 was treated with a Silk Vista Baby. Two were treated with 2 pipeline embolization devices telescopically overlapped across the pseudoaneurysm. All devices deployed successfully. No pseudoaneurysm recurrence or rebleeding occurred. No parent artery occlusion or stenosis was observed, and complete pseudoaneurysm occlusion was observed in 4 patients (in 2 patients, follow-up imaging could not be obtained). CONCLUSION: With proper antiplatelet regimens, flow diverter stents can be used safely to successfully treat complex acute iatrogenic injuries. Early repeat angiogram is needed when immediate postinjury imaging does not discover the point of vessel injury.
- 23 September 2024
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 28 (6) , 808-816
Treatment of Acute Iatrogenic Cerebrovascular Injury Using Flow Diverter Stents
BACKGROUND AND OBJECTIVES: Iatrogenic cerebrovascular injury can cause intracranial hemorrhage and pseudoaneurysm formation, putting patients at high risk for postoperative bleeding. No consensus for management exists. This study describes endovascular treatment of these acute injuries with flow diverter stents. METHODS: Electronic medical records were retrospectively reviewed for injury type and etiology, timing of diagnosis, and endovascular management, including antiplatelet regimens, embolization results, and clinical outcome. RESULTS: Six patients were included. Three suffered an injury to the internal carotid artery, 1 suffered an injury to the left anterior cerebral artery, 1 suffered an injury to the right posterior cerebral artery, and 1 suffered an injury to the basilar artery. Four of the 6 injuries occurred during attempted tumor resection, 1 occurred during cerebrospinal fluid leak repair, and 1 occurred during an ophthalmic artery aneurysm clipping. All injuries resulted in pseudoaneurysm formation. Four were immediately detected on angiography; 2 were initially negative on imaging. Five were treated with a pipeline embolization device, and 1 was treated with a Silk Vista Baby. Two were treated with 2 pipeline embolization devices telescopically overlapped across the pseudoaneurysm. All devices deployed successfully. No pseudoaneurysm recurrence or rebleeding occurred. No parent artery occlusion or stenosis was observed, and complete pseudoaneurysm occlusion was observed in 4 patients (in 2 patients, follow-up imaging could not be obtained). CONCLUSION: With proper antiplatelet regimens, flow diverter stents can be used safely to successfully treat complex acute iatrogenic injuries. Early repeat angiogram is needed when immediate postinjury imaging does not discover the point of vessel injury.
- 1 February 2023
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 84 (S 01) , S1-S344
Olfactory Functional Outcomes Following Expanded Endoscopic Endonasal Surgery for Non-Pituitary Anterior Skull Base Tumors
Background: Olfactory dysfunction is one of the risks of the endoscopic endonasal approach (EEA) for intracranial tumor resection. This risk may be increased for suprasellar and anterior cranial fossa tumors due to the proximity of the olfactory tract/bulb, the need for more extensive bony exposure, and the need for more extensive sinonasal dissection, including the harvest of a nasoseptal flap. Although olfactory dysfunction poses a significant impact on patients' quality of life, the likelihood of this complication following expanded EEA is not well understood. In this study, we investigate olfactory functional outcomes following EEA for non-pituitary pathologies to better elucidate the risk of iatrogenic hyposmia/anosmia. Methods: Adult patients undergoing EEA for non-pituitary extrasellar tumor resection between October 2018 and June 2022 were prospectively identified. Each patient underwent a preoperative University of Pennsylvania Smell Identification Test (UPSIT), which is scored out of 40 points. All operative approaches were expanded EEAs that included drilling of the tuberculum sellae, planum sphenoidale, fovea ethmoidalis, and/or cribriform plate. A second UPSIT was then administered postoperatively. A paired t-test was used to compare UPSIT scores pre- and postoperatively. Univariate analysis was then performed to identify preoperative predictors of greater decreases in UPSIT postoperatively. Results: Twelve patients were identified for this study. The median age was 60 (range: 37–74) and 7 (58.3%) patients were female. Ten (83.3%) patients had meningiomas, 1 (8.3%) patient had a sinonasal carcinoma, and 1 (8.3%) patient had a craniopharyngioma. Among the meningiomas, 7 (70%) were tuberculum sellae meningiomas, 2 (20%) were olfactory groove meningiomas, and 1 (10%) was an inferior frontal convexity meningioma. A pedicled nasoseptal flap was used in 11 (91.7%) cases. The mean preoperative UPSIT score was 30. A postoperative UPSIT was administered a mean of 2.7 months following EEA. The mean postoperative UPSIT was 27, and there was no significant difference between preoperative and postoperative UPSIT scores (p = 0.09). Preoperative olfactory status (p = 0.11), age (p = 0.24), preoperative visual deficits (p = 0.80), and smoking history (p = 0.31) were not found to be predictive of a greater change in UPSIT scores postoperatively. Conclusion: The risk of olfactory dysfunction following EEA has not previously been well understood or characterized. In this study, we found no significant decrease in olfactory function following expanded EEA with nasoseptal flap reconstruction. Larger studies are warranted to further elucidate predictors of olfactory outcomes following EEA to better counsel patients on risks of this complication. Article published online: 01 February 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 February 2023
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 84 (S 01) , S1-S344
Olfactory Functional Outcomes Following Expanded Endoscopic Endonasal Surgery for Non-Pituitary Anterior Skull Base Tumors
Background: Olfactory dysfunction is one of the risks of the endoscopic endonasal approach (EEA) for intracranial tumor resection. This risk may be increased for suprasellar and anterior cranial fossa tumors due to the proximity of the olfactory tract/bulb, the need for more extensive bony exposure, and the need for more extensive sinonasal dissection, including the harvest of a nasoseptal flap. Although olfactory dysfunction poses a significant impact on patients' quality of life, the likelihood of this complication following expanded EEA is not well understood. In this study, we investigate olfactory functional outcomes following EEA for non-pituitary pathologies to better elucidate the risk of iatrogenic hyposmia/anosmia. Methods: Adult patients undergoing EEA for non-pituitary extrasellar tumor resection between October 2018 and June 2022 were prospectively identified. Each patient underwent a preoperative University of Pennsylvania Smell Identification Test (UPSIT), which is scored out of 40 points. All operative approaches were expanded EEAs that included drilling of the tuberculum sellae, planum sphenoidale, fovea ethmoidalis, and/or cribriform plate. A second UPSIT was then administered postoperatively. A paired t-test was used to compare UPSIT scores pre- and postoperatively. Univariate analysis was then performed to identify preoperative predictors of greater decreases in UPSIT postoperatively. Results: Twelve patients were identified for this study. The median age was 60 (range: 37–74) and 7 (58.3%) patients were female. Ten (83.3%) patients had meningiomas, 1 (8.3%) patient had a sinonasal carcinoma, and 1 (8.3%) patient had a craniopharyngioma. Among the meningiomas, 7 (70%) were tuberculum sellae meningiomas, 2 (20%) were olfactory groove meningiomas, and 1 (10%) was an inferior frontal convexity meningioma. A pedicled nasoseptal flap was used in 11 (91.7%) cases. The mean preoperative UPSIT score was 30. A postoperative UPSIT was administered a mean of 2.7 months following EEA. The mean postoperative UPSIT was 27, and there was no significant difference between preoperative and postoperative UPSIT scores (p = 0.09). Preoperative olfactory status (p = 0.11), age (p = 0.24), preoperative visual deficits (p = 0.80), and smoking history (p = 0.31) were not found to be predictive of a greater change in UPSIT scores postoperatively. Conclusion: The risk of olfactory dysfunction following EEA has not previously been well understood or characterized. In this study, we found no significant decrease in olfactory function following expanded EEA with nasoseptal flap reconstruction. Larger studies are warranted to further elucidate predictors of olfactory outcomes following EEA to better counsel patients on risks of this complication. Article published online: 01 February 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 14 February 2022
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 84 (02) , 157-163
Discontinuation of Postoperative Prophylactic Antibiotics for Endoscopic Endonasal Skull Base Surgery
Background Postoperative prophylactic antibiotic usage for endoscopic skull base surgery varies based on the institution as evidence-based guidelines are lacking. The purpose of this study is to determine whether discontinuing postoperative prophylactic antibiotics in endoscopic endonasal cases led to a difference in central nervous system (CNS) infections, multi-drug resistant organism (MDRO) infections, or other postoperative infections. Methods This quality improvement study compared outcomes between a retrospective cohort (from September 2013 to March 2019) and a prospective cohort (April 2019 to June 2019) after adopting a protocol to discontinue prophylactic postoperative antibiotics in patients who underwent endoscopic endonasal approaches (EEAs). Our primary end points of the study included the presence of postoperative CNS infection, Clostridium difficile (C. diff), and MDRO infections. Results A total of 388 patients were analyzed, 313 in the pre-protocol group and 75 in the post-protocol group. There were similar rates of intraoperative cerebrospinal fluid leak (56.9 vs. 61.3%, p = 0.946). There was a statistically significant decrease in the proportion of patients receiving IV antibiotics during their postoperative course (p = 0.001) and those discharged on antibiotics (p = 0.001). There was no significant increase in the rate of CNS infections in the post-protocol group despite the discontinuation of postoperative antibiotics (3.5 vs. 2.7%, p = 0.714). There was no statistically significant difference in postoperative C. diff (0 vs. 0%, p = 0.488) or development of MDRO infections (0.3 vs 0%, p = 0.624). Conclusion Discontinuation of postoperative antibiotics after EEA at our institution did not change the frequency of CNS infections. It appears that discontinuation of antibiotics after EEA is safe.
- 14 February 2022
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 84 (02) , 157-163
Open AccessDiscontinuation of Postoperative Prophylactic Antibiotics for Endoscopic Endonasal Skull Base Surgery
Background Postoperative prophylactic antibiotic usage for endoscopic skull base surgery varies based on the institution as evidence-based guidelines are lacking. The purpose of this study is to determine whether discontinuing postoperative prophylactic antibiotics in endoscopic endonasal cases led to a difference in central nervous system (CNS) infections, multi-drug resistant organism (MDRO) infections, or other postoperative infections. Methods This quality improvement study compared outcomes between a retrospective cohort (from September 2013 to March 2019) and a prospective cohort (April 2019 to June 2019) after adopting a protocol to discontinue prophylactic postoperative antibiotics in patients who underwent endoscopic endonasal approaches (EEAs). Our primary end points of the study included the presence of postoperative CNS infection, Clostridium difficile (C. diff), and MDRO infections. Results A total of 388 patients were analyzed, 313 in the pre-protocol group and 75 in the post-protocol group. There were similar rates of intraoperative cerebrospinal fluid leak (56.9 vs. 61.3%, p = 0.946). There was a statistically significant decrease in the proportion of patients receiving IV antibiotics during their postoperative course (p = 0.001) and those discharged on antibiotics (p = 0.001). There was no significant increase in the rate of CNS infections in the post-protocol group despite the discontinuation of postoperative antibiotics (3.5 vs. 2.7%, p = 0.714). There was no statistically significant difference in postoperative C. diff (0 vs. 0%, p = 0.488) or development of MDRO infections (0.3 vs 0%, p = 0.624). Conclusion Discontinuation of postoperative antibiotics after EEA at our institution did not change the frequency of CNS infections. It appears that discontinuation of antibiotics after EEA is safe.
- 13 May 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (8) , 1437-1443
Simultaneous Multislice for Accelerating Diffusion MRI in Clinical Neuroradiology Protocols
BACKGROUND AND PURPOSE: Diffusion MR imaging sequences essential for clinical neuroradiology imaging protocols may be accelerated with simultaneous multislice acquisitions. We tested whether simultaneous multislice–accelerated diffusion data were clinically equivalent to standard acquisitions. MATERIALS AND METHODS: In this retrospective study, clinical diffusion sequences obtained before and after implementation of 2-slice simultaneous multislice acceleration and an altered diffusion gradient sampling scheme using the same 3T MRI scanner and 20-channel coil (n = 25 per group) were independently and blindly evaluated by 2 neuroradiologists for perceived quality, artifacts, and overall diagnostic utility. Diffusion tractography was performed in 13 patients both with and without 2-slice simultaneous multislice acceleration (b = 0, 1000, 2000 s/mm2; 60 directions). The corticospinal tract and arcuate fasciculus ipsilateral to the lesion were generated using the same ROIs and then blindly assessed by a neurosurgeon for anatomic fidelity, perceived quality, and impact on surgical management. Tract volumes were compared for spatial overlap. RESULTS: Two-slice simultaneous multislice diffusion reduced acquisition times from 141 to 45 seconds for routine diffusion and from 7.5 to 5.9 minutes for diffusion tractography using 3T MR imaging. The simultaneous multislice–accelerated diffusion sequence was rated equivalent for diagnostic utility despite reductions to perceived image quality. Simultaneous multislice–accelerated diffusion tractography was rated clinically equivalent. Dice similarity coefficients between routine and simultaneous multislice–generated corticospinal tract and arcuate fasciculus tract volumes were 0.78 (SD, 0.03) and 0.71 (SD, 0.05), respectively. CONCLUSIONS: Two-slice simultaneous multislice diffusion appeared clinically equivalent for standard acquisitions and diffusion tractography. Simultaneous multislice makes it feasible to acquire higher angular and q-space-resolution diffusion acquisitions required for translating advanced diffusion models into clinical practice.
- 13 May 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (8) , 1437-1443
Simultaneous Multislice for Accelerating Diffusion MRI in Clinical Neuroradiology Protocols
BACKGROUND AND PURPOSE: Diffusion MR imaging sequences essential for clinical neuroradiology imaging protocols may be accelerated with simultaneous multislice acquisitions. We tested whether simultaneous multislice–accelerated diffusion data were clinically equivalent to standard acquisitions. MATERIALS AND METHODS: In this retrospective study, clinical diffusion sequences obtained before and after implementation of 2-slice simultaneous multislice acceleration and an altered diffusion gradient sampling scheme using the same 3T MRI scanner and 20-channel coil (n = 25 per group) were independently and blindly evaluated by 2 neuroradiologists for perceived quality, artifacts, and overall diagnostic utility. Diffusion tractography was performed in 13 patients both with and without 2-slice simultaneous multislice acceleration (b = 0, 1000, 2000 s/mm2; 60 directions). The corticospinal tract and arcuate fasciculus ipsilateral to the lesion were generated using the same ROIs and then blindly assessed by a neurosurgeon for anatomic fidelity, perceived quality, and impact on surgical management. Tract volumes were compared for spatial overlap. RESULTS: Two-slice simultaneous multislice diffusion reduced acquisition times from 141 to 45 seconds for routine diffusion and from 7.5 to 5.9 minutes for diffusion tractography using 3T MR imaging. The simultaneous multislice–accelerated diffusion sequence was rated equivalent for diagnostic utility despite reductions to perceived image quality. Simultaneous multislice–accelerated diffusion tractography was rated clinically equivalent. Dice similarity coefficients between routine and simultaneous multislice–generated corticospinal tract and arcuate fasciculus tract volumes were 0.78 (SD, 0.03) and 0.71 (SD, 0.05), respectively. CONCLUSIONS: Two-slice simultaneous multislice diffusion appeared clinically equivalent for standard acquisitions and diffusion tractography. Simultaneous multislice makes it feasible to acquire higher angular and q-space-resolution diffusion acquisitions required for translating advanced diffusion models into clinical practice.
- Open Access
- 3 November 2016
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 38 (2) , 387-390
Palliative CT-Guided Cordotomy for Medically Intractable Pain in Patients with Cancer
SUMMARY: Palliative cervical cordotomy can be performed via percutaneous radiofrequency ablation of the lateral C1–2 spinothalamic tract. This rare procedure can be safe, effective, and advantageous in mitigating medically intractable unilateral extremity pain for selected patients with end-stage cancer. This report reviews the indications, techniques, risks, and potential benefits of cordotomy. We describe our recent experience treating 3 patients with CT-guided C1–2 cordotomy and provide the first characterization of spinal cord diffusion MR imaging changes associated with successful cordotomy.
- 3 November 2016
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 38 (2) , 387-390
Open AccessPalliative CT-Guided Cordotomy for Medically Intractable Pain in Patients with Cancer
SUMMARY: Palliative cervical cordotomy can be performed via percutaneous radiofrequency ablation of the lateral C1–2 spinothalamic tract. This rare procedure can be safe, effective, and advantageous in mitigating medically intractable unilateral extremity pain for selected patients with end-stage cancer. This report reviews the indications, techniques, risks, and potential benefits of cordotomy. We describe our recent experience treating 3 patients with CT-guided C1–2 cordotomy and provide the first characterization of spinal cord diffusion MR imaging changes associated with successful cordotomy.